knowledge -WSS

knowledge

author：fashion 2025-09-05 09:09:50 - browse：49435

Abbott's heart device TriClip on a gradient dark blue background — coverage from STAT — The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. Illustration: STAT; Photo: Courtesy Abbott

An advisory panel to the Food and Drug Administration voted in favor of a new device from Abbott meant to treat patients with tricuspid heart valve disease. All but one of the 14 panelists said the treatment’s benefits outweighed its risks. The FDA tends to follow advisory panel recommendations.

“If we can help symptoms with this at a low cost in terms of risk, I think it makes a lot of sense,” said James Blankenship, a panelist and cardiologist at the University of New Mexico.

The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. The condition impacts 1.6 million people in the United States. Symptoms include fatigue, swelling, and atypical heart rhythms. In severe cases, the condition can lead to heart failure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： FDA approves RSV monoclonal antibody for infants, toddlers

focus

WSS

AI can’t replace a physician’s gut feeling

Custom gene therapy hints at new path for rare disease treatments

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

How Medicaid coverage policies for immigrants impact new moms

hotspot

knowledge

entertainment

In Memoriam: Notable people who died in 2023

Cigna wins case to block Amy Bricker's move to CVS

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

WHO calls for emergency meeting on new China virus, as cases spread

The high cost of giving birth even with insurance

Medicare to cover more brain scans for Alzheimer’s patients

Supreme Court strikes down use of affirmative action

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Medical leaders decry Supreme Court decision on affirmative action

How faith leaders like me can help address America's obesity epidemic

explore

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

The system is set up to fail children with medical complexity

A public scorecard can help hold safety

Pharma companies must ensure equitable access to obesity drugs

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

California wildfire smoke linked to 52,000 early deaths, study says

focus

knowledge

hotspot

focus